UK solar energy company invests in USyd start-up


Wednesday, 13 April, 2016

UK solar energy company invests in USyd start-up

University of Sydney spin-off company Gelion has secured an $11 million commitment from Armstrong Energy, a major utility-scale solar energy company in the UK, which will see the latter invest in the start-up’s ambitious plan to make commercially viable, nanostructured, gel-based batteries.

Gelion is the brainchild of renewable energy and catalysis expert Professor Thomas Maschmeyer, who is also the director of the soon-to-be-launched Australian Institute for Nanoscale Science and Technology. The company relies on Professor Maschmeyer’s breakthrough design of nanostructured gels aimed at significantly outcompeting current lithium-ion technology in terms of charging/discharging speeds, size, safety, durability and price.

The initial market is storage in buildings — both residential and commercial. As explained by Professor Maschmeyer, “The idea is to build houses with batteries inherently included as part of their structure, ready to take advantage of rapidly improving, solar energy technology and also to serve as a buffer for the grid, enabling an ever greater share of renewables to be connected while grid stability is maintained.”

Now that a major international investment has been secured, a full commercial demonstration prototype could be developed within four years. This would enable subsequent engineering for mass production, readying the development for broad commercial introduction.

Image caption: Professor Thomas Maschmeyer. Image credit: University of Sydney.

Related News

Flinders works on method to filter nanoplastics from water

Flinders University researchers are working on a method capable of detecting nanoplastics using...

March workshops seek to empower NT flood evacuees

In March, a workshop series will bring together researchers and community members to co-design a...

Colon cancer DNA in blood can guide chemo decisions

A simple blood test could change how doctors decide which patients with colon cancer need...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd